Table of Contents
Epilepsy Research and Treatment
Volume 2010 (2010), Article ID 725696, 10 pages
http://dx.doi.org/10.1155/2010/725696
Review Article

Evolution and Prospects for Intracranial Pharmacotherapy for Refractory Epilepsies: The Subdural Hybrid Neuroprosthesis

Comprehensive Epilepsy Center, New York University School of Medicine, NYU Langone Medical Center, 223 East 34th Street, New York, NY 10016, USA

Received 11 September 2009; Accepted 5 November 2009

Academic Editor: Annamaria Vezzani

Copyright © 2010 Nandor Ludvig et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Smith, S. E. Krahl, R. A. Browning, and E. J. Barea, “Rapid cessation of focally induced generalized seizures in rats through microinfusion of lidocaine hydrochloride into the focus,” Epilepsia, vol. 34, no. 1, pp. 43–53, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. H. G. Eder, D. B. Jones, and R. S. Fisher, “Local perfusion of diazepam attenuates interictal and ictal events in the bicuculline model of epilepsy in rats,” Epilepsia, vol. 38, no. 5, pp. 516–521, 1997. View at Google Scholar · View at Scopus
  3. N. Ludvig, “Drug deliveries into the microenvironment of electrophysiologically monitored neurons in the brain of behaving rats and monkeys,” in Neural Prostheses for Restoration of Sensory and Motor Function, J. K. Chapin and K. A. Moxon, Eds., pp. 263–283, CRC Press, New York, NY, USA, 2000. View at Google Scholar
  4. N. Ludvig and H. M. Tang, “Cellular electrophysiological changes in the hippocampus of freely behaving rats during local microdialysis with epileptogenic concentration of N-methyl-D-aspartate,” Brain Research Bulletin, vol. 51, no. 3, pp. 233–240, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. R. E. Fischell, D. R. Fischell, and R. M. Adrian, “Responsive implantable system for the treatment of neurological disorders,” US patent no. 6134474, 2000, http://www.uspto.gov/.
  6. A. G. Stein, H. G. Eder, D. E. Blum, A. Drachev, and R. S. Fisher, “An automated drug delivery system for focal epilepsy,” Epilepsy Research, vol. 39, no. 2, pp. 103–114, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. P. Jacobs, G. D. Fischbach, M. R. Davis et al., “Future directions for epilepsy research,” Neurology, vol. 57, no. 9, pp. 1536–1542, 2001. View at Google Scholar · View at Scopus
  8. B. Litt, R. Esteller, J. Echauz et al., “Epileptic seizures may begin hours in advance of clinical onset: a report of five patients,” Neuron, vol. 30, no. 1, pp. 51–64, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Ludvig and L. Kovacs, “Hybrid neuroprosthesis for the treatment of brain disorders,” US patent no. 6497699, 2002, http://www.uspto.gov/.
  10. R. S. Fisher and J. Ho, “Potential new methods for antiepileptic drug delivery,” CNS Drugs, vol. 16, no. 9, pp. 579–593, 2002. View at Google Scholar · View at Scopus
  11. R. J. Tamargo, L. A. Rossell, E. H. Kossoff, B. M. Tyler, M. G. Ewend, and J. J. Aryanpur, “The intracerebral administration of phenytoin using controlled-release polymers reduces experimental seizures in rats,” Epilepsy Research, vol. 48, no. 3, pp. 145–155, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Anschel, E. L. Ortega, A. C. Kraus, and R. S. Fisher, “Focally injected adenosine prevents seizures in the rat,” Experimental Neurology, vol. 190, no. 2, pp. 544–547, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. E. Nilsen and H. R. Cock, “Focal treatment for refractory epilepsy: hope for the future?” Brain Research Reviews, vol. 44, no. 2-3, pp. 141–153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. D. A. Turner, M. A. L. Nicolelis, and K. Landingham, “Pre-ictal seizure detection and demand treatment strategies for epilepsy,” in Modern Neurosurgery: Clinical Translation of Neuroscience Advances, D. A. Turner, Ed., pp. 105–118, CRC Press, New York, NY, USA, 2005. View at Google Scholar
  15. R.-J. Lohman, L. Liu, M. Morris, and T. J. O'Brien, “Validation of a method for localised microinjection of drugs into thalamic subregions in rats for epilepsy pharmacological studies,” Journal of Neuroscience Methods, vol. 146, no. 2, pp. 191–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. D. Heiss, S. Walbridge, P. Morrison et al., “Local distribution and toxicity of prolonged hippocampal infusion of muscimol,” Journal of Neurosurgery, vol. 103, no. 6, pp. 1035–1045, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Ludvig, R. I. Kuzniecky, S. L. Baptiste et al., “Epidural pentobarbital delivery can prevent locally induced neocortical seizures in rats: the prospect of transmeningeal pharmacotherapy for intractable focal epilepsy,” Epilepsia, vol. 47, no. 11, pp. 1792–1802, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Ludvig, L. G. Sheffield, H. M. Tang, S. L. Baptiste, O. Devinsky, and R. I. Kuzniecky, “Histological evidence for drug diffusion across the cerebral meninges into the underlying neocortex in rats,” Brain Research, vol. 1188, no. 1, pp. 228–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Ludvig, S. L. Baptiste, H. M. Tang et al., “Localized transmeningeal muscimol prevents neocortical seizures in rats and nonhuman primates: therapeutic implications,” Epilepsia, vol. 50, no. 4, pp. 678–693, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Ludvig, H. M. Tang, S. L. Baptiste et al., “Developing a subdural hybrid neuroprosthesis (HNP) to treat intractable focal epilepsy,” in Advances in the Application of Technology to Epilepsy: The CIMIT/NIO Epilepsy Innovation Summit, S. C. Schachter, J. Guttag, S. Schiff, D. C. Schomer, and Summit Contributors, Eds., vol. 16, pp. 3–46, Epilepsy & Behavior, 2009. View at Google Scholar
  21. M. Gasior, N. A. White, and M. A. Rogawski, “Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists ω-conotoxin GVIA and ω-conotoxin MVIIA,” Journal of Pharmacology and Experimental Therapeutics, vol. 323, no. 2, pp. 458–468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. E. John, S. L. Baptiste, L. G. Sheffield et al., “Transmeningeal delivery of GABA to control neocortical seizures in rats,” Epilepsy Research, vol. 75, no. 1, pp. 10–17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. W. C. Stacey and B. Litt, “Technology insight: neuroengineering and epilepsy—designing devices for seizure control,” Nature Clinical Practice Neurology, vol. 4, no. 4, pp. 190–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Madhavan, P. Mirowski, N. Ludvig et al., “Effects of subdural application of lidocaine in patients with focal epilepsy,” Epilepsy Research, vol. 78, no. 2-3, pp. 235–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Barcia and J. M. Gallego, “Intraventricular and intracerebral delivery of anti-epileptic drugs in the kindling model,” Neurotherapeutics, vol. 6, no. 2, pp. 337–343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Rogawski, “Convection-enhanced delivery in the treatment of epilepsy,” Neurotherapeutics, vol. 6, no. 2, pp. 344–351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Sendroy Jr. and H. A. Collison, “Determination of human body volume from height and weight,” Journal of Applied Physiology, vol. 21, no. 1, pp. 167–172, 1966. View at Google Scholar · View at Scopus
  28. R. S. Fisher, S. Uematsu, G. L. Krauss et al., “Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures,” Epilepsia, vol. 33, no. 5, pp. 841–851, 1992. View at Publisher · View at Google Scholar · View at Scopus
  29. W. H. Theodore and R. Fisher, “Brain stimulation for epilepsy,” Acta Neurochirurgica. Supplement, vol. 97, part 2, pp. 261–272, 2007. View at Google Scholar · View at Scopus
  30. K. N. Fountas, J. R. Smith, A. M. Murro, J. Politsky, Y. D. Park, and P. D. Jenkins, “Implantation of a closed-loop stimulation in the management of medically refractory focal epilepsy: a technical note,” Stereotactic and Functional Neurosurgery, vol. 83, no. 4, pp. 153–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Worrell, R. Wharen, R. Goodman et al., “Safety and evidence for efficacy of an implantable responsive neurostimulator (RNS) for the treatment of medically intractable partial onset epilepsy in adults,” Epilepsia, vol. 46, supplement 8, p. 226, 2005. View at Google Scholar
  32. W. S. Anderson, E. H. Kossoff, G. K. Bergey, and G. I. Jallo, “Implantation of a responsive neurostimulator device in patients with refractory epilepsy,” Neurosurgical Focus, vol. 25, no. 3, article E12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Noe', J. Nissinen, A. Pitkänen et al., “Gene therapy in epilepsy: the focus on NPY,” Peptides, vol. 28, no. 2, pp. 377–383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Riban, H. L. Fitzsimons, and M. J. During, “Gene therapy in epilepsy,” Epilepsia, vol. 50, no. 1, pp. 24–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Huber, V. Padrun, N. Déglon, P. Aebischer, H. Möhler, and D. Boison, “Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 13, pp. 7611–7616, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. K. W. Thompson and L. M. Suchomelova, “Transplants of cells engineered to produce GABA suppress spontaneous seizures,” Epilepsia, vol. 45, no. 1, pp. 4–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Rothman and X.-F. Yang, “Local cooling: a therapy for intractable neocortical epilepsy,” Epilepsy Currents, vol. 3, pp. 153–156, 2003. View at Google Scholar
  38. M. J. Brodie, “Diagnosing and predicting refractory epilepsy,” Acta Neurologica Scandinavica, vol. 112, supplement 181, pp. 36–39, 2005. View at Google Scholar · View at Scopus
  39. G. D. Cascino, “When drugs and surgery don't work,” Epilepsia, vol. 49, supplement 9, pp. 79–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. Brodie, S. D. Shorvon, R. Canger et al., “Commission on European affairs: appropriate standards of epilepsy care across Europe,” Epilepsia, vol. 38, no. 11, pp. 1245–1250, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. O. Devinsky, “Patients with refractory seizures,” The New England Journal of Medicine, vol. 340, no. 20, pp. 1565–1570, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. B. C. Callaghan, K. Anand, D. Hesdorffer, W. A. Hauser, and J. A. French, “Likelihood of seizure remission in an adult population with refractory epilepsy,” Annals of Neurology, vol. 62, no. 4, pp. 382–389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Choi, G. Heiman, D. Pandis et al., “Seizure remission and relapse in adults with intractable epilepsy: a cohort study,” Epilepsia, vol. 49, no. 8, pp. 1440–1445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. W. M. Chardack, A. A. Gage, A. J. Federico, G. Schimert, and W. Greatbatch, “Clinical experience with an implantable pacemaker,” Annals of the New York Academy of Sciences, vol. 11, pp. 1075–1092, 1964. View at Google Scholar
  45. R. Terry, W. B. Tarver, and J. Zabara, “An implantable neurocybernetic prosthesis system,” Epilepsia, vol. 31, supplement 2, pp. S33–S37, 1990. View at Google Scholar · View at Scopus
  46. J. K. Chapin and M. A. L. Nicolelis, “Brain control of sensorimotor prostheses,” in Neural Prostheses for Restoration of Sensory and Motor Function, J. K. Chapin and K. A. Moxon, Eds., pp. 235–261, CRC Press, New York, NY, USA, 2000. View at Google Scholar
  47. P. R. Kennedy and B. King, “Dynamic interplay of neural signals during the emergence of cursor related cortex in a human implanted with the neurotrophic electrode,” in Neural Prostheses for Restoration of Sensory and Motor Function, J. K. Chapin and K. A. Moxon, Eds., pp. 211–233, CRC Press, New York, NY, USA, 2000. View at Google Scholar
  48. C. Haberler, F. Alesch, P. R. Mazal et al., “No tissue damage by chronic deep brain stimulation in Parkinson's disease,” Annals of Neurology, vol. 48, no. 3, pp. 372–376, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. R. C. Collins, “Anticonvulsant effects of muscimol,” Neurology, vol. 30, no. 6, pp. 575–581, 1980. View at Google Scholar · View at Scopus
  50. G. D. Frye, T. J. McCown, and G. R. Breese, “Characterization of susceptibility to audiogenic seizures in ethanol-dependent rats after microinjection of γ-aminobutyric acid (GABA) agonists into the inferior colliculus, substantia nigra or medial septum,” Journal of Pharmacology and Experimental Therapeutics, vol. 227, no. 3, pp. 663–670, 1983. View at Google Scholar · View at Scopus
  51. N. Ludvig and S. L. Moshe, “Different behavioral and electrographic effects of acoustic stimulation and dibutyryl cyclic AMP injection into the inferior colliculus in normal and in genetically epilepsy-prone rats,” Epilepsy Research, vol. 3, no. 3, pp. 185–190, 1989. View at Google Scholar · View at Scopus
  52. S. Piredda and K. Gale, “A crucial epileptogenic site in the deep prepiriform cortex,” Nature, vol. 317, no. 6038, pp. 623–625, 1985. View at Google Scholar · View at Scopus
  53. M. Kokaia, P. Aebischer, E. Elmer et al., “Seizure suppression in kindling epilepsy by intracerebral implants of GABA- but not by noradrenaline-releasing polymer matrices,” Experimental Brain Research, vol. 100, no. 3, pp. 385–394, 1994. View at Google Scholar · View at Scopus
  54. I. H. Stevenson and M. J. Turnbull, “A study of the factors affecting the sleeping time following intracerebroventricular administration of pentobarbitone sodium: effect of prior administration of centrally active drugs,” British Journal of Pharmacology, vol. 50, no. 4, pp. 499–511, 1974. View at Google Scholar · View at Scopus
  55. N. Ludvig, L. Kovacs, R. I. Kuzniecky et al., “Apparatus and method for monitoring and treatment of brain disorders,” US patent application no. 11/224661, 2005.
  56. N. Ludvig, R. Rizzolo, H. M. Tang, R. I. Kuzniecky, and W. K. Doyle, “Microelectrode-equipped subdural therapeutic agent delivery strip,” US patent serial no. 61082706, 2008.
  57. J. Y. Wang, T. L. Yaksh, and V. L.W. Go, “In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures,” Brain Research, vol. 280, no. 1, pp. 105–117, 1983. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Y. Wang, T. L. Yaksh, G. J. Harty, and V. L. Go, “Neurotransmitter modulation of VIP release from rat cerebral cortex,” American Journal of Physiology, vol. 250, pp. R104–R111, 1986. View at Google Scholar
  59. D. R. Cornblath and J. H. Ferguson, “Distribution of radioactivity from topically applied [H3] acetylcholine in relation to seizure,” Experimental Neurology, vol. 50, no. 2, pp. 495–504, 1976. View at Publisher · View at Google Scholar · View at Scopus
  60. W. Löscher and D. Schmidt, “Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs,” Epilepsia, vol. 47, no. 8, pp. 1253–1284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Brailowsky, M. Kunimoto, C. Silva-Barrat, C. Menini, and R. Naquet, “Electroencephalographic study of the GABA-withdrawal syndrome in rats,” Epilepsia, vol. 31, no. 4, pp. 369–377, 1990. View at Google Scholar · View at Scopus
  62. T. C. Jacob, S. J. Moss, and R. Jurd, “GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition,” Nature Reviews Neuroscience, vol. 9, no. 5, pp. 331–343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Long, A. Mercer, R. Begum, G. J. Stephens, T. S. Sihra, and J. N. Jovanovic, “Nerve terminal GABAA receptors activate Ca2+/calmodulin-dependent signaling to inhibit voltage-gated Ca2+ influx and glutamate release,” The Journal of Biological Chemistry, vol. 284, no. 13, pp. 8726–8737, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. M. S. Duchowny, A. S. Harvey, M. R. Sperling, and P. D. Williamson, “Indications and criteria for surgical interventions,” in Epilepsy: A Comprehensive Textbook, J. Engel Jr. and T. A. Pedley, Eds., pp. 1677–1685, Lippincott-Raven, Philadelphia, Pa, USA, 1997. View at Google Scholar
  65. N. Ludvig, H. M. Tang, S. L. Baptiste, O. Devinsky, and R. I. Kuzniecky, “Neocortical multineuron recording as a potential tool for predicting focal seizures,” Epilepsia, vol. 48, supplement 6, p. 388, 2007. View at Google Scholar
  66. H. Tang, P. Mirowski, S. Baptiste, O. Devinsky, R. I. Kuzniecky, and N. Ludvig, “Evidence for increased neuronal electrophysiological activity before EEG seizure onset in the rat neocortical seizure focus,” Epilepsia, vol. 49, supplement 7, p. 382, 2008. View at Google Scholar
  67. N. S. Artan, P. Mirowski, H. M. Tang et al., “Detecting abnormally large-amplitude multi-neuron bursts before focal neocortical EEG seizure onset in freely behaving rats,” Epilepsia, vol. 50, p. 391, 2009. View at Google Scholar